Data as of Aug 16, 2026 · Based on 3,131,739 AI responses across 10,525 prompts · See how Parse measures this
TrialAssure LINK AItrialassure.comLINK AI is TrialAssure’s highly configurable medical writing AI platform for the pharmaceutical industry that drafts, translates, and refines clinical, regulatory, and plain-language documents, now with direct Microsoft Word integration. It digests information from existing documents and data sources to generate ready-to-review drafts such as Plain Language Summaries, Clinical Study Protocols, CSR, ICF, and SAP, while offering templates, glossaries, translation, readability tools, and collaborative workflows. The solution aims to shorten document timelines and support global transparency requirements, claiming to cut four weeks from a typical six-week drafting process and help teams meet 30+ country lay-summary obligations.
TrialAssureTrialAssure LINK AISources
trialassure.com shapes more of what AI says about TrialAssure LINK AI than any other source, at 57% of its citations.
alphalifesci.com · parse.gl · taskade.com
The market map
Clinical Trial Operations Platforms →Where AI ranks TrialAssure LINK AI
Excerpts where TrialAssure LINK AI appeared in the AI's answer
TrialAssure LINK AI : Focuses heavily on the document lifecycle for clinical trials, including plain language summaries (PLS) and regulatory disclosures.
TrialAssure LINK AI : Specifically designed to ingest unstructured clinical protocols and spit out compliant Plain Language Summaries (PLS) and consent drafts
